Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes

Christopher E Dandoy1, Jeffery J Auletta2, Priscila Badia1

  • 1Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; University of Cincinnati College of Medicine, Cincinnati, Ohio.

Summary

The Engraft Learning Health Network (LHN) fosters collaboration among diverse stakeholders to enhance outcomes in transplant and cellular therapy (TCT). By standardizing practices and using real-world data, it aims to reduce mortality and improve survivorship.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
337
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
66.8K